Key Findings
- The UK mobile phlebotomy market grew by an estimated 34% in 2025, far outpacing the broader diagnostics sector growth of 12%.
- An estimated 4.3 million blood tests were performed at patient homes in 2025, up from approximately 3.2 million in 2024.
- NHS blood test waiting times remain at 2 to 4 weeks on average, driving patients towards private and mobile alternatives that offer same-day to 48-hour turnaround.
- 78% of patients who have experienced both clinic and home blood collection report a preference for home-based services.
- Manchester recorded the fastest year-on-year growth at 41%, overtaking Birmingham as the second-largest regional market.
- API-first booking platforms now process an estimated 18% of all mobile phlebotomy appointments, up from 7% in 2024, reflecting growing integration with laboratory information systems and GP practice software.
Market Overview
The UK phlebotomy sector encompasses all blood collection services delivered to patients, spanning NHS hospital pathology departments, GP-based phlebotomy clinics, private laboratory walk-in centres, and the rapidly expanding mobile and home-visit segment. The total UK blood testing market is valued at an estimated £2.8 billion in 2025, with mobile phlebotomy accounting for approximately £340 million of that figure, up from an estimated £255 million in 2024.
Several converging factors are driving the growth of mobile phlebotomy. The NHS continues to face a significant diagnostic backlog, with many trusts reporting blood test waiting times of two to four weeks. Simultaneously, patient expectations have shifted: the convenience economy has normalised on-demand services in healthcare just as it has in retail and transport. The COVID-19 pandemic permanently altered patient willingness to attend clinical settings for routine procedures, and home blood collection has benefited from that behavioural shift.
Corporate wellness programmes represent another significant demand driver. Large employers are increasingly offering health screening as an employee benefit, and mobile phlebotomy is the most practical delivery mechanism for workplace blood testing. The number of corporate clients booking through platforms like Lola Dispatch grew by an estimated 52% in 2025.
On the supply side, the freelance phlebotomy workforce has expanded as qualified practitioners recognise the earning potential and scheduling flexibility of mobile work. Platforms that connect phlebotomists with clients have made it significantly easier to build a viable independent practice without the overhead of running a standalone clinic.
Key Statistics
4.3M
Blood tests performed at home in the UK (2025)
Up from 3.2M in 2024
34%
Year-on-year growth in mobile phlebotomy
Outpacing overall diagnostics sector (12%)
2-4 wks
Average wait for a GP blood test
NHS England average across trusts
<48 hrs
Average wait for mobile phlebotomist
Same-day available in major cities
78%
Patients prefer home blood collection
When given the choice vs. clinic visit
£35-£45
Average mobile phlebotomy appointment cost
Single-patient standard collection
Regional Demand
Mobile phlebotomy demand is concentrated in major urban areas but is growing fastest in mid-size cities where NHS waiting times are longest. The table below shows the top ten cities by share of total UK mobile phlebotomy appointments in 2025.
| Rank | City | Market Share | YoY Growth |
|---|---|---|---|
| 1 | London | 22.4% | +28% |
| 2 | Manchester | 8.7% | +41% |
| 3 | Birmingham | 7.9% | +33% |
| 4 | Leeds | 5.2% | +36% |
| 5 | Glasgow | 4.8% | +29% |
| 6 | Edinburgh | 4.1% | +31% |
| 7 | Bristol | 3.6% | +38% |
| 8 | Liverpool | 3.3% | +27% |
| 9 | Cardiff | 2.9% | +35% |
| 10 | Sheffield | 2.7% | +30% |
Remaining 34.4% of demand is distributed across 40+ smaller cities and rural areas. Source: Lola Dispatch platform data and market estimates, 2025.
Most Commonly Ordered Blood Tests
Full blood counts remain the single most ordered test type in mobile phlebotomy, accounting for nearly one quarter of all collections. Metabolic panels and liver function tests together make up another third. The distribution below is based on aggregated Lola Dispatch appointment data from 2025.
| Test Type | Share of Orders |
|---|---|
| Full Blood Count (FBC) | 24% |
| Metabolic Panel (U&E) | 18% |
| Liver Function (LFT) | 14% |
| Thyroid Function (TFT) | 12% |
| HbA1c / Glucose | 10% |
| Lipid Profile | 8% |
| Hormone Panel | 6% |
| Vitamin & Mineral | 5% |
| Other / Specialist | 3% |
Many appointments involve multiple test types. Percentages reflect the primary test category for each appointment. Source: Lola Dispatch platform data, 2025.
Workforce
The UK phlebotomy workforce is estimated at approximately 22,000 to 25,000 practising phlebotomists, including those employed by NHS trusts, private clinics, and independent mobile practitioners. Of these, an estimated 4,500 to 5,500 work primarily in mobile or freelance roles, a figure that has grown by roughly 40% over the past two years.
The shift towards freelance work is driven by several factors. Mobile phlebotomists working through platforms typically earn £25 to £60 per appointment, with the ability to set their own hours and coverage areas. Many combine platform work with part-time NHS or clinic roles. The average mobile phlebotomist on Lola Dispatch completes between 15 and 25 appointments per week.
Entry requirements remain consistent: a recognised Level 3 phlebotomy qualification, an Enhanced DBS certificate, professional indemnity insurance, and proof of right to work in the UK. The Institute of Biomedical Science (IBMS) and NHS Health Education England continue to oversee training standards. Demand for qualified phlebotomists currently outstrips supply in most regions outside London, creating opportunities for new entrants to the profession.
22,000-25,000
Estimated practising phlebotomists in the UK
4,500-5,500
Working in mobile or freelance roles
~40%
Growth in freelance workforce since 2023
Technology Trends
Technology adoption within mobile phlebotomy has accelerated significantly. The most notable trends include the rise of API-first platforms, real-time digital tracking, AI-assisted document verification, and integration with downstream diagnostic systems.
API-First Booking Platforms
Platforms offering REST APIs for programmatic job creation now handle an estimated 18% of mobile phlebotomy appointments, up from 7% in 2024. This reflects growing demand from laboratories, GP systems, and telehealth providers that need to embed phlebotomy booking into existing workflows. Lola Dispatch, for example, exposes 25+ API endpoints covering the complete job lifecycle.
Real-Time Digital Tracking
Live ETA tracking and automated status notifications are becoming standard. Clients and patients now expect visibility into phlebotomist arrival times, sample collection progress, and job completion. WebSocket-based real-time updates have replaced the older polling model on most modern platforms.
AI in Document Verification
Artificial intelligence is being used to streamline phlebotomist onboarding. AI-powered document extraction can read DBS certificates, qualification certificates, and ID documents, reducing manual verification time by up to 60%. This allows platforms to onboard new phlebotomists faster while maintaining compliance standards.
Integration with Lab Systems
The chain from blood collection to laboratory analysis is increasingly digital. Modern platforms integrate with Laboratory Information Management Systems (LIMS) to automatically communicate sample collection details, expected arrival times, and required test panels, reducing transcription errors and improving turnaround times.
Predictions for 2027
1. Mobile phlebotomy will exceed 6 million home appointments annually
If current growth rates persist, the number of blood tests performed at patient homes in the UK will surpass 6 million by the end of 2027. This would represent approximately 8% of all blood tests in the UK being performed outside traditional clinical settings.
2. NHS commissioning of private mobile phlebotomy will formalise
Several NHS trusts have already begun piloting formal referral pathways to mobile phlebotomy platforms as a way to reduce diagnostic backlogs. By 2027, we expect this to become a widespread commissioning model, particularly for housebound patients and those in areas with limited clinic access.
3. Consolidation among mobile phlebotomy platforms
The current market includes a mix of national platforms, regional operators, and individual freelancers. As the market matures, we expect consolidation around two to three major platforms that offer national coverage, API integration, compliance management, and competitive phlebotomist networks.
4. Point-of-care testing will complement but not replace venepuncture
While finger-prick and point-of-care testing devices continue to improve, venous blood collection will remain the gold standard for the majority of diagnostic panels. Mobile phlebotomists may increasingly carry point-of-care devices for rapid screening alongside their standard venepuncture equipment.
Methodology & Disclaimer
This report is based on a combination of Lola Dispatch platform data (anonymised and aggregated), publicly available NHS Digital statistics, Institute of Biomedical Science (IBMS) workforce surveys, and market estimates derived from industry consultations conducted by Lola Health in Q1 2026.
All statistics presented are market estimates and should be treated as indicative rather than definitive. The mobile phlebotomy sector is still emerging and comprehensive official data is limited. Where ranges are provided (e.g., workforce figures), they reflect the uncertainty inherent in extrapolating from available data sources.
This report is published for informational purposes only. Lola Health makes no warranty regarding the accuracy or completeness of the data presented. Readers should conduct their own due diligence before making business decisions based on these figures. For questions about this report, contact support@loladispatch.com.
Ready to get started with Lola Dispatch?
Whether you are a healthcare business looking to book mobile phlebotomists or a qualified phlebotomist seeking flexible work, Lola Dispatch makes it simple.